Accuray Incorporated

Equities

ARAY

US0043971052

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 11:07:58 2024-07-12 am EDT			5-day change	1st Jan Change
1.945 ^USD	-1.27%		+11.92%	-31.98%

Jun. 27	Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care	CI
Jun. 20	Accuray, TrueNorth Medical Physics Collaborate on Radiation Oncology Support	MT

Accuray Incorporated Appoints Beverly A. Huss to the Company's Board of Directors

January 11, 2018 at 04:01 pm EST

Accuray Incorporated announced the appointment of Beverly A. Huss to the company's Board of Directors, effective January 7, 2018. Ms. Huss also currently serves on the boards of Qool Therapeutics Inc., Surefire Medical Inc., and Madorra.

Latest news about Accuray Incorporated

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care	Jun. 27	CI
Accuray, TrueNorth Medical Physics Collaborate on Radiation Oncology Support	Jun. 20	MT
Accuray Incorporated and TrueNorth Medical Physics LLC Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients	Jun. 20	CI
Sector Update: Health Care Stocks Softer Wednesday Afternoon	Jun. 12	MT
Accuray Secures Approval for Precision Treatment Planning System	Jun. 12	MT
Accuray Incorporated Announces Approval of the Accuray Precision Treatment Planning System by China's National Medical Products Administration	Jun. 12	CI
Accuray Incorporated Announces Executive Changes, Effective May 17, 2024	May. 10	CI
Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q3 Revenue $101.1M, vs. Street Est of $113.6M	May. 01	MT
Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q3 Revenue $101.1M, vs. Street Est of $113.6M	May. 01	MT
Transcript : Accuray Incorporated, Q3 2024 Earnings Call, May 01, 2024	May. 01
Accuray Incorporated Provides Earnings Guidance for the Year 2024	May. 01	CI
Accuray Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 01	CI
Accuray Incorporated Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024	Apr. 25	CI
Accuray Incorporated Expands Global Training Center Network with Opening of New Facility in Genolier, Switzerland	Apr. 18	CI
Accuray Incorporated Announces New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can Be Effectively Treated in 5 Days Using the Accuray CyberKnife System	Mar. 26	CI
Roth MKM Starts Accuray With Buy Rating, $9 Price Target	Feb. 13	MT
Quebec Cancer Center Is First in Canada to Treat Cancer Patients Using the Accuray Radixact System	Feb. 13	CI
Transcript : Accuray Incorporated, Q2 2024 Earnings Call, Jan 31, 2024	Jan. 31
Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q2 Revenue $107.2M, vs. Street Est of $106.7M	Jan. 31	MT
Accuray Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 31	CI
Accuray Incorporated Reaffirms Revenue Guidance for the Third Quarter and Full Fiscal Year 2024	Jan. 31	CI
Accuray Incorporated Announces the Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray Cyberknife System	Jan. 25	CI
Accuray Insider Sold Shares Worth $161,624, According to a Recent SEC Filing	Dec. 05	MT
B. Riley Trims Accuray's Price Target to $6.50 From $7.50 on Lower Multiple, Maintains Buy Rating	Nov. 09	MT
Transcript : Accuray Incorporated, Q1 2024 Earnings Call, Nov 07, 2023	Nov. 07

Chart Accuray Incorporated

Duration

Period

More charts

Company Profile

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-14 - Q4 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Accuray Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.97 USD

Average target price

6 USD

Spread / Average Target

+204.57%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ACCURAY INCORPORATED	-31.98%	196M
THERMO FISHER SCIENTIFIC	+3.39%	207B
DANAHER CORPORATION	+7.01%	182B
INTUITIVE SURGICAL, INC.	+31.70%	157B
BOSTON SCIENTIFIC CORPORATION	+33.30%	113B
SIEMENS HEALTHINEERS AG	+5.06%	66.91B
EDWARDS LIFESCIENCES CORPORATION	+21.10%	55.95B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.92%	47.01B
AGILENT TECHNOLOGIES, INC.	-4.57%	38.17B
GE HEALTHCARE TECHNOLOGIES INC.	+4.10%	36.49B

Other Advanced Medical Equipment & Technology